1. Food and Agriculture Organization of the United Nations and World Health Organization. Health and nutritional properties of probiotics in food, including powder milk with live lactic acid bacteria. World Health Organization Web site.http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf.
2. Markowiak P, Slizewska K. Effects of probiotics, prebiotics, and synbiotics on human health.Nutrients. 2017; 9(1021):1-30. doi: 10.3390/ nu9091021.
3. Parvez S, Malik KA, Ah Kang S, Kim HY. Probiotics and their fermented food products are beneficial for health,J. Appl. Microbiol. 2006; 100 (6), 1171-1185.
4. Isolauri E., Kirjavainen P.V., Salminen S., Probiotics: a role in the treatment of intestinal infection and inflammation?,Gut. 2002; 50 (Suppl III), 54-59.
5. Madsen KL. The use of probiotics in gastrointestinal disease,Can. J. Gastroenterol. 2001; 15; 817-822.
6. Reuter G. TheLactobacillus and Bifidobacterium microflora of the human intestine: composition and succession, Curr. Issues Intest. Microbiol. 2001; 2: 43-53.
7. Katz JA and Fiocchi C. Probiotic therapy of IBD,Inflamm. Bowel Dis. 2001; 2: 106-111.
8. Guslandi M, Mezzi G, Sorghi M, Testoni PA.Saccharomyces boulardii in maintenance treatment of Crohn’s disease, Dig. Dis. Sci. 2000; 45: 1462-1464.
9. Metchnikoff E. Sur la flore du corps humain.Manchester Lit Philos Soc. 1901; 45: 1-38.
10. Metchnikoff E, Mitchell PC, editors. Essais Optimistes. London: Heinemann; 1907
11. Van de Water J, Keen CL, Gershwin ME. The influence of chronic yogurt consumption on immunity,J. Nutr. 1999; 129 (7 Suppl): 1492S-5S.
12. Johnson IT. New food components and gastrointestinal health,Proc. Nutr. Soc. 2001; 60(4): 481-488.
13. Reyed MR. Probiotics: A New Strategies for Prevention and Therapy of Diarrhea Disease,J. Appl. Sci. Res. 2007; 3(4): 291-299.
14. Leblanc J, Fliss I, Matar C, Induction of a humoral immune response following anEscherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus-fermented milk. Clin. Diagn. Lab. Immunol. 2004; 11(6): 1171-1181.
15. Havenaar R, Huis in’t Veld JHJ. Probiotics: A general view. In: Wood BJB, editor. The Lactic Acid Bacteria in Health and Disease. London: Elsevier Applied Science; 1992; pp. 151-170.
16. Hill C, Guarner F, Rei G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic.Nature Reviews Gastroenterology & Hepatology. 2014; 11:506-514. doi: 10.1038/ nrgastro.2014.66.
17. Wilkins T, Sequoia J. Probiotics for Gastrointestinal Conditions: A Summary of the Evidence.Am Fam Physician. 2017;96(3):170-178.
18. Anbari K, Firouzi M, Abbaszadeh S. Probiotics and gastrointestinal diseases: A promising complementary medicine resource for treatment of gastrointestinal disorders and diseases.Journal of Pharmacy & Pharmacognosy Research. 2019; 7 (3): 193-199.
19. Markowiak P, Slizewska K. Effects of probiotics, prebiotics, and synbiotics on human health.Nutrients. 2017; 9(1021):1-30. doi: 10.3390/nu909102.
20. Gibson RG, Roberfroid MB. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics.The Journal of Nutrition. 1995; 125:1401-1412. DOI: 10.1093/jn/125.6.1401.
21. Gibson GR, Probert HM, van Loo J, Rastall RA, Roberfroid M. Dietary modulation of the human colonic microbiota: Updating the concept of the prebiotics.Nutrition Research Reviews. 2004; 17:259-275. doi: 10.1079/ NRR200479.
22. Food and Agriculture Organization. FAO Technical Meeting on Prebiotics: Food Quality and Standards Service (AGNS), Food and Agriculture Organization of the United Nations (FAO). Rome, Italy: FAO Technical Meeting Report; FAO. 2007; pp. 15-16.
23. Skalkam ML, Wiese M, Nielsen DS,van Zanten G. In Vitro Screening and Evaluation of Synbiotics. Copenhagen, Denmark: University of Copenhagen; 2016; (Chapter 33). pp. 477-486.
24. Cencic A, Chingwaru W. The role of functional foods, nutraceuticals, and food supplements in intestinalhealth.Nutrients. 2010; 2:611-625. doi:10.3390/nu2060611.
25. Amara AA, Shibl A. Role of probiotics in health improvement, infection control and disease treatment and management.Saudi Pharmaceutical Journal. 2015; 23:107-114. DOI: 10.1016/jjsps.2013.07.001.
26. Wegh CAM, Geerlings SY, Knol J, Roeselers G, Belzer C. Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond. Int J Mol Sci.2019; 20(19). pii: E4673. doi: 10.3390/ijms20194673.
27. Taverniti V, Guglielmetti S. The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept).Genes Nutr. 2011; 6(3):261-74. doi: 10.1007/s12263-011-021.
28. Geraldo BMC, Batalha MN, Milhan NVM, Rossoni RD, Scorzoni L, Anbinder AL.Heat-killed Lactobacillus reuteri and cell-free culture supernatant have similar effects to viable probiotics during interaction with Porphyromonas gingivalis. J Periodontal Res. 2019; doi: 10.1111/jre.12704.
29. Xiong W., Brown CT., Morowitz MJ., Banfield JF., Hettich R.L. Genome-resolved metaproteomic characterization of preterm infant gut microbiota development reveals species-specific metabolic shifts and variabilities during early life.Microbiome. 2017; 5: 72,
30. EFSA Journal, 2018; Guidance on the characterisation of microorganisms used as feed additives or as production organisms. doi: 10.2903/j.efsa.2018.5206
31. Amara AA, Shibl A. Role of probiotics in health improvement, infection control and disease treatment and management.Saudi Pharmaceutical Journal. 2015; 23:107-114. DOI: 10.1016/j. jsps.2013.07.001
32. O’Toole PW, Marchesi JR, Hill C. Next-generation probiotics: The spectrum from probiotics to live biotherapeutics.Nature Microbiology. 2017; 2:1-6 (article number: 17057). DOI: 10.1038/ nmicrobiol.2017.57.
33. Gaggia F, Mattarelli P, Biavati B. Probiotics and prebiotics in animal feeding for safe food production. International Journal of Food Microbiology. 2010; 141: S15-S28. DOI: 10.1016/j.ijfoodmicro.2010.02.031
34. Yalınay Çırak M. Functional Dairy Products and Probiotics in Infectious Diseases. In: Development and Manufacture of Yogurt and Other Functional Dairy Products; Yıldız F. Ed.; Chapter 14, Page 391-411, Taylor and Francis Group, LLC, USA, ISBN:978-1-4200-8207-4, 2010.
35. Vandenbergh PA. Lactic acid bacteria, their metabolic products and interference with microbial growth.FEMS Microbiology Reviews. 1993; 12:221-238. doi: 10.1111/j.1574- 6976.1993.tb00020.x
36. Guillot JF. Probiotic feed additives.Journal of Veterinary Pharmacology and Therapeutics. 2003; 26:52-55. doi: 10.1046/J.1365-2885.26
37. Isolauri E, Sutas Y, Kankaanpaa P, Arvilommi H, Salminen S. Probiotics: Effects on immunity.American Journal of Clinical Nutrition. 2001; 73:444-450. doi: 10.1093/ajcn/73.2.444s
38. Brandao RL, Castro IM, Bambirra EA, Amaral SC, Fietto LG, Tropia MJM. Intracellular signal triggered by cholera toxin inSaccharomyces boulardii and Saccharomyces cerevisiae. Applied and Environmental Microbiology. 1998; 64:564-568
39. Schachtsiek M, Hammes WP, Hertel C. Characterization ofLactobacillus coryniformis DSM 20001T surface protein CPF mediating coaggregation with and aggregation among pathogens. Applied and Environmental Microbiology. 2004; 70:7078-7085. doi: 10.1128/AEM.70.12.7078-7085.2004
40. Oelschlaeger A. Mechanisms of probiotic actions—A review. International Journal of Medical Microbiology. 2010; 300:57-62. doi: 10.1016/j.ijmm.2009.08.005
41. Sniffen JC, McFarland LV, Evans CT, Goldstein EJC. Choosing an appropriate probiotic product for your patient: An evidence-based practical guide.PLoS One. 2018; 13(12): e0209205. doi: 10.1371/journal.pone.0209205.
42. Morris G, Fernandes BS, Puri BK, Walker AJ, Carvalho AF, Berk M, Aust NZ J. Leaky brain in neurological and psychiatric disorders: Drivers and consequences.Psychiatry. 2018; 52(10):924-948. doi: 10.1177/0004867418796955.
43. Olveira G, González-Moleroa I. An update on probiotics, prebiotics and symbiotics in clinical nutrition.Endocrinología y Nutrición. 2016; 63(9): 482-494. doi: 10.1016/j. endoen.2016.10.011
44. Floch MH, Walker WA, Sanders ME, Nieuwdorp M, Kim AS, Brenner DA, et al. Recommendations for probiotic use-2015update: Proceedings and consensus opinion.Journal of Clinical Gastroenterology. 2015; 49 (Suppl. 1): S69-S73. doi: 10.1016/j.iccn.2010.07.001
45. McFarland LV. Probiotics for the primary and secondary prevention ofC. difficile infections: A meta-analysis and systematic review. Antibiotics. 2015; 4:160-178. DOI: 10.3390/ antibiotics4020160
46. Yang Y., Pei J., Qin Z., Wei L. Efficacy of probiotics to prevent and/or alleviate childhood rotavirus infections.Journal of Functional Foods. 2019; 90-99, doi.org/10.1016/j.jff.2018.10.036
47. Guslandi M. Role of probiotics in Crohn’s disease and in pouchitis. J Clin Gastroenterol 2015; 49(1): S46-S59. doi: 10.1097/ MCG.0000000000000351.
48. Chibbar R, Dieleman LA. Probiotics in the management of ulcerative colitis. J Clin Gastroenterol 2015; 49(1): S50-S55. doi: 10.1097/ MCG.0000000000000368
49. Domingo JJS. Review of the role of probiotics in gastrointestinal diseases in adults. Gastroenterología y Hepatología. 2017; 40(6):417-429. doi: 10.1016/j. gastre.2016.12.001
50. Tong JL, Ran ZH, Shen J, Zhang CX, Xiao SD. Meta-analysis: The effect of supplementation with probiotics on eradication rates and adverse events duringHelicobacter pylori eradication therapy. Alimentary Pharmacology & Therapeutics. 2007; 25:155-168. doi: 10.1111/j.1365-2036.2006.03179.x
51. Chávez-Tapia NC, González- Rodríguez L, Jeong MS, López-Ramírez Y, Barbero-Becerra V, Juárez-Hernández E, et al. Current evidence on the use of probiotics in liver diseases.Journal of Functional Foods. 2015; 17:137-151. doi: 10.1016/j.jff.2015.05.009.
52. Xu RY, Wan YP, Fang QY, Lu W, Cai W. Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model.Journal of Clinical Biochemistry and Nutrition. 2012; 50(1):72-77. doi: 10.3164/ jcbn.11-38
53. Lee DK, Kang JY, Shin HS, Park IH, Ha NJ. Antiviral activity ofBifidobacterium adolescentis SPM0212 against hepatitis B virus. Archives of Pharmacal Research. 2013; 36(12): 1525-1532. doi: 10.1007/ s12272-013-0141-3.
54. Zhang W, Gu Y, Chen Y, Deng H, Chen L, Che S, et al. Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis. Eur J Gastroenterol Hepatol 2010; 22(12):1481-1486. doi: 10.1097/MEG.0b013e32833eb8b0.
55. Waigankar SS, Patel V. Role of probiotics in urogenital healthcare. Journal of Midlife Health.2011; 2:5-10. doi: 10.4103/0976-7800.83253
56. Petricevic L, Domig K, Nierscher F, Sandhofer M, Fidesser M, Krondorfer I, et al. Characterisation of the vaginalLactobacillus microbiota associated with preterm delivery. Scientific Reports. 2014; 4:1-6 (article number: 5136). doi: 10.1038/srep05136.
57. Commane D, Hughes R, Shortt C, Rowland I. The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutation Research. 2005; 591:276-289. doi: 10.1016/j. mrfmmm.2005.02.027.
58. Reid G, Bruce A. Probiotics to prevent urinary tract infections: The rationale and evidence.World Journal of Urology. 2006; 24:28-32. doi: 10.1007/ s00345-005-0043-1.
59. Pierro FD, Polzonetti V, Patrone V, Morelli L. Microbiological Assessment of the Quality of Some Commercial Products Marketed asLactobacillus crispatus-Containing Probiotic Dietary Supplements. Microorganisms. 2019;3;7(11). pii: E524. doi: 10.3390/microorganisms7110524.
60. Homayouni A, Payahoo L, Azizi A. Effects of probiotics on lipid profile: A review. Am J Food Technol 2012; 7(5):251-265. doi: 10.3923/ajft.2012.251.265.
61. Ooi LG, Liong MT. Cholesterol- lowering effects of probiotics and prebiotics: A review ofin vivo and in vitro findings. Int J Molecular Sci 2010;11: 2499-2522. doi: 10.3390/ijms11062499.
62. Ranjbar F, Akbarzadeh F, Homayouni A. Probiotics usage in heart disease and psychiatry, chapter 61, in book:Probiotics, Prebiotics, and Synbiotics Bioactive Foods in Health Promotion: Probiotics and Prebiotics, Edited by R. Ross Watson and V. R. Preedy. Elsevier Inc., Academic Press, London, UK, 2016; pp.807-811.
63. Marini G, Sitzia E, Panatta ML, De Vincentiis GC. Pilot study to explore the prophylactic efficacy of oral probioticStreptococcus salivarius K12 in preventing recurrent pharyngo-tonsillar episodes in pediatric patients. Int J Gen Med. 2019; 12:213-217. doi: 10.2147/IJGM.S168209.
64. Burton J, Drummond B, Chilcott C, Tagg J, Thomson W, Hale J, et al. Influence of the probioticStreptococcus salivarius strain M18 on indices of dental health in children: A randomized double-blind,placebo-controlled trial. J Med Microbiol 2013; 62:875-884. doi: 10.1099/ jmm.0.056663-0.
65. Zupancic K, Kriksic V, Kovacevic I, Kovacevic D. Influence of Oral ProbioticStreptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review. Probiotics Antimicrob Proteins. 2017; 9(2):102-110. doi: 10.1007/s12602-017-9261-2.
66. Bowen DM. Probiotics and oral health.Journal of Dental Hygiene. 2013; 87:5-9.
67. Vonk RJ, Reckman GA, Harmsen HJ, Priebe MG. Probiotics and lactose intolerance. In: Rigobelo EC, editor.Probiotics. Rijeka, Crotatia: InTech; 2012; doi: 10.5772/51424.
68. Main, B.S.; Minter, M.R. Microbial immuno-communication in neurodegenerative diseases. Front. Neurosci.2017; 11: 151. [CrossRef] [PubMed]
69. Ait-Belgnaoui, A.; Durand, H.; Cartier, C.; Chaumaz, G.; Eutamene, H.; Ferrier, L.; Houdeau, J.; Bueno, L.;
Theodorou, V. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an 
acute psychological stress in rats. Psychoneuroendocrinology 2012, 37: 1885–1895. [CrossRef] [PubMed]
70. Hoyles, L.; Snelling, T.; Umlai, U.-K.; Nicholson, J.K.; Carding, S.R.; Glen, R.C.; McArthur, S. Microbiome–host systems interactions: Protective effects of propionate upon the blood-brain barrier. Microbiome2018; 6: 55. 
[CrossRef] [PubMed]
71. Sarkar A, Harty S, Lehto SM, Moeller AH, Dinan TG, Dunbar RIM, Cryan JF, Burnet PWJ. The Microbiome in Psychology and Cognitive Neuroscience. Trends Cogn Sci. 2018; 22(7):611-636. doi: 10.1016/j.tics.2018.04.006.
72. Sarkar A, Lehto SM, Harty S, Dinan TG, Cryan JF, Burnet PWJ. Psychobiotics and the Manipulation of Bacteria-Gut-Brain Signals. Trends Neurosci. 2016; 39(11):763-781. doi: 10.1016/j.tins.2016.09.002.
73. Dowlati, Y. et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010; 67: 446–457.
74. Udina, M. et al. Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J. Clin. Psychiatry 2012; 73: 1128–1138.
75. McNutt, M.D. et al. Neurobehavioral effects of interferon in patients with hepatitis C: symptom dimensions and responsiveness to paroxetine. Neuropsychopharmacology 3 2012; 7: 1444–1454.
76. Lu, Y. et al. BDNF: a key regulator for protein synthesis- dependent LTP and long-term memory? Neurobiol. Learn. Mem. 2008; 89: 312–323.
77. Heldt, S.A. et al. Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol. Psychiatry 2007; 12, 656–670
78. Martinowich, K. and Lu, B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 2008; 33:73–83.
79. Tao Y, Leng SX, Zhang H. Ketogenic diet: an effective treatment approach for neurodegenerative diseases. Curr Neuropharmacol. 2022; 30.
80. Zandifar A, Badrfam R, Mohammaditabar M, Kargar B, Goodarzi S, Hajialigol A, Ketabforoush S, Heidari A, Fathi H, Shafiee A, Pourjafar H. The Effect of Prebiotics and Probiotics on Levels of Depression, Anxiety, and Cognitive Function: A Meta-Analysis of Randomized Clinical Trials. Brain Behav. 2025 Mar;15(3): e70401.
81. Moshfeghinia R, Nemati H, Ebrahimi A, Shekouh D, Karami S, Eraghi MM, Mohagheghzadeh H, Hunter J, Pasalar M. The impact of probiotics, prebiotics, and synbiotics on depression and anxiety symptoms of patients with depression: A systematic review and meta-analysis. J Psychiatr Res. 2025 Aug;188:104-116.
82. Asad A, Kirk M, Zhu S, Dong X, Gao M.Effects of Prebiotics and Probiotics on Symptoms of Depression and Anxiety in Clinically Diagnosed Samples: Systematic Review and Meta-analysis of Randomized Controlled Trials. Nutr Rev. 2025 Jul 1;83(7):e1504-e1520
83. Pandey KR, Naik SR, Vakil BV. Probiotics, prebiotics and synbiotics—A review. J Food Sci Technol 2015; 52(12):7577-7587. doi: 10.1007/ s13197-015-1921-1.
84. Tufarelli V, Laudadio V. An overview on the functional food concept: Prospectives and applied researches in probiotics, prebiotics and synbiotics. J Exp Biol Agricult Sci 2016; 4:274-278. doi: 10.18006/2016.4(3S).273.278.
85. Okusaeva K, Fitzgerald GF, Sinderen D. Carbohydrate metabolism in bifidobacteria. Genes & Nutrition. 2011; 6:285-306. doi: 10.1007/ s12263-010-0206-6.
86. Cencic A, Chingwaru W. The role of functional foods, nutraceuticals, and food supplements in intestinal health. Nutrients. 2010; 2(6):611-625. doi: 10.3390/nu2060611.
87. Lindsay JO, Whelan K, Stagg AJ, Gobin P, HO A-H, Rayment N, et al. Clinical, microbiological, and immunological effects of fructooligosaccharide in patients with Crohn’s disease. Gut. 2006; 55(3):348-355. doi: 10.1136/gut.2005.074971.
88. Chen J, Yu Y, Sun S, Yu W, Lei Y, Lu C, Zhai J, Bai F, Ren F, Wang R. Probiotics and Prebiotics: Meeting Dietary Requirements for Optimal Health and Planetary Sustainability. J Nutr. 2025 Aug;155(8):2519-2533.
89. de Oliveira LIG, de Araujo ARR, Pimentel TC, Capozzi V, Alves Bezerra TK, Magnani M. Probiotics and Prebiotics in Foodborne Illness: Mechanisms, Applications, and Future Directions. J Food Prot. 2025 Aug 22;88(9):100584
90. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007; 449(7164):804-10.

s91.       Sniffen JC, McFarland LV, Evans CT, Goldstein EJC. Choosing an appropriate probiotic product for your patient: An evidence-based practical guide. 2018; PLoS ONE 13(12):1-22.